Table 1.
Overall population characteristics at baseline.
| Variables | CAD (n = 52) |
CTR (n = 40) |
p value |
|---|---|---|---|
| Demographic characteristics | |||
| Age, years | 63.5 ± 9.7 | 58.5 ± 7.0 | 0.004 |
| Male gender, number (%) | 40 (76.9) | 22 (55.0) | 0.014 |
| Clinical characteristics | |||
| Weight, kg | 75.6 ± 13.8 | 78.1 ± 13.7 | 0.390 |
| BMI, kg/m2 | 26 ± 5.2 | 27.5 ± 4.1 | 0.080 |
| Active smokers, number (%) | 6 (11.5) | 6 (15) | 0.630 |
| Biochemical | |||
| Total cholesterol, mg/dL | 190.7 ± 44.2 | 212.5 ± 29.0 | 0.004 |
| LDL cholesterol, mg/dL | 121.8 ± 35.6 | 139.5 ± 32.4 | 0.020 |
| HDL cholesterol, mg/dL | 48.0 ± 10.6 | 52.7 ± 12.9 | 0.004 |
| Triglycerides, mg/dL | 104.0 ± 41.6 | 130.3 ± 82.4 | 0.070 |
| Fasting glycemia, mg/dL | 117.7 ± 28.1 | 107.0 ± 31.3 | 0.190 |
| Creatinine, mg/dL | 149.9 ± 77.3 | 125.2 ± 51.8 | 0.070 |
| Comorbidities | |||
| Diabetes, number (%) | 7 (13.5) | 1 (2.5) | 0.080 |
| Hypertension, number (%) | 48 (92.3) | 17 (42.5) | 0.005 |
| Hypercholesterolemia, number (%) |
29 (55.8) | 9 (22.5) | 0.001 |
| Obesity, number (%) | 1 (1.9) | 5 (12.5) | 0.070 |
| Medications | |||
| Aspirin, number (%) | 33 (63.5) | 0 (0) | p < 0.001 |
| Statins, number (%) | 28 (53.9) | 4 (10) | p < 0.001 |
| Oral hypoglycemics, number (%) |
7 (13.5) | 1 (2.5) | 0.160 |
| Antihypertensive, number (%) |
48 (92.3) | 13 (32.5) | p < 0.001 |
Characteristics of the study groups: CAD patients (n = 52) and CTR subjects (n = 40). Values are presented as mean ± SD or in absolute numbers (percentage of total).